• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vertex Pharmaceuticals (NQ:VRTX)

    430.44 -3.87 (-0.89%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vertex Pharmaceuticals

    < Previous 1 2
    ...
    19 20 21 22 23 24 25 26 27
    ...
    73 74 Next >
    News headline image
    3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
    Vertex should have a future full of bright tomorrows. 
    Via The Motley Fool
    News headline image
    Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗
     
    Via Benzinga
    News headline image
    Biotech And Life Science Sector Update Summer Of 2024 ↗
    It’s the slowest week of the year, we are at the market top and most earnings reports are good. 
    Via Talk Markets
    News headline image
    Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics ↗
    Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC. 
    Via Benzinga
    News headline image
    Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗
     
    Via Benzinga
    News headline image
    Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗
     
    Via Benzinga
    News headline image
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today ↗
     
    Via Benzinga
    News headline image
    Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗
     
    Via Benzinga
    News headline image
    Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead ↗
    Vertex Pharmaceuticals has a lot going for it. 
    Via The Motley Fool
    News headline image
    Vertex to Participate in Upcoming September Investor Conferences
    From Vertex Pharmaceuticals Incorporated
    Via Business Wire
    News headline image
    Biotech Bull Market: 3 Ways To Play It ↗
    Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally. 
    Via Talk Markets
    Topics Economy
    News headline image
    Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings ↗
    Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities... 
    Via Benzinga
    News headline image
    These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond ↗
    It's always a good time to invest cash in quality businesses. 
    Via The Motley Fool
    News headline image
    3 Fantastic Growth Stocks to Buy in August ↗
    These stocks should keep up their winning ways. 
    Via The Motley Fool
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
     
    Via Benzinga
    News headline image
    3 Biotech Stocks to Buy on the Dip: August 2024 ↗
    These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning. 
    Via InvestorPlace
    News headline image
    Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them ↗
    These technologies could be game-changers. And they could make forward-thinking investors a lot of money. 
    Via The Motley Fool
    News headline image
    2 Biotech Stocks to Buy Hand Over Fist in August ↗
    Both of these biotechs are highly innovative companies. 
    Via The Motley Fool
    News headline image
    The 3 Best Biotech Stocks to Buy in August 2024 ↗
    These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead. 
    Via InvestorPlace
    News headline image
    Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
    From Vertex Pharmaceuticals
    Via Business Wire
    News headline image
    Is It Too Late to Buy Vertex Pharmaceuticals Stock? ↗
    Shares of the rare disease drugmaker are already up more than 40% over the past year. 
    Via The Motley Fool
    News headline image
    Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 ↗
    Great companies are found in every type of market landscape. 
    Via The Motley Fool
    News headline image
    3 Biotech Stocks on Track for 50% Returns (or More) by 2028 ↗
    Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028! 
    Via InvestorPlace
    News headline image
    Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker ↗
    The biotech recently became a commercial-stage company. 
    Via The Motley Fool
    News headline image
    3 Unstoppable Stocks to Buy in August ↗
    It's not hard to envision how all three of these stocks can deliver exceptional growth. 
    Via The Motley Fool
    News headline image
    Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now ↗
    These two healthcare companies have far more upside potential than Johnson & Johnson. 
    Via The Motley Fool
    News headline image
    3 Biotech Stocks That Could Have Investors Grinning Soon ↗
    Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential. 
    Via InvestorPlace
    News headline image
    Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday? ↗
    Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and... 
    Via Benzinga
    Topics Economy
    News headline image
    Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline ↗
    Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain... 
    Via Benzinga
    News headline image
    Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second. ↗
    Vertex's first loss in years is a big nothingburger. 
    Via The Motley Fool
    < Previous 1 2
    ...
    19 20 21 22 23 24 25 26 27
    ...
    73 74 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.